Mesoblast (MESO) Return on Sales [ROS] (2014 - 2023)
Mesoblast (MESO) reported Return on Sales [ROS] of 214.92% for the year ended Jun 30, 2026, down 286.21 percentage points from 501.13% a year earlier.
Powered by 
Analysis
Mesoblast (MESO) Return on Sales [ROS] (2014 - 2023) Analysis & Trends
Dating back to the year ended Jun 30, 2015, Mesoblast's Return on Sales [ROS] record includes 12 years.
- Return on Sales [ROS] has a five-year change of +1699.23 percentage points (years ended Jun 2021 to Jun 2026).
- The figure for the year ended Jun 30, 2026 ranks as the lowest annual Return on Sales [ROS] since the year ended Jun 30, 2022.
- According to Business Quant data, Return on Sales [ROS] came in at 501.13% in the year ended Jun 30, 2025 (-695.04 pp), 1196.17% in the year ended Jun 30, 2024 (+25.70 pp), 1170.47% in the year ended Jun 30, 2023 (+2236.71 pp) and -1066.24% in the year ended Jun 30, 2022 (+418.07 pp).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 34.46% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 24.35% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 36.01% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.74% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 29.12% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.79% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 41.71% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 32.98% |
| 10 | Mesoblast | 1.81 Bn | 1.38 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2023 | -818.47% |
| Mar 31, 2023 | -704.59% |
| Dec 31, 2022 | -860.78% |
| Sep 30, 2022 | -824.22% |
| Jun 30, 2022 | -772.03% |
| Mar 31, 2022 | -867.03% |
| Dec 31, 2021 | -866.34% |
| Sep 30, 2021 | -516.61% |
| Jun 30, 2021 | -1,180.03% |
| Mar 31, 2021 | -1,157.46% |
| Dec 31, 2020 | -964.93% |
| Sep 30, 2020 | -1,635.86% |
| Jun 30, 2020 | -4,573.89% |
| Mar 31, 2020 | -110.52% |
| Dec 31, 2019 | -1,053.99% |
| Sep 30, 2019 | -22.52% |
| Jun 30, 2019 | -1,022.11% |
| Mar 31, 2019 | -1,924.02% |
| Dec 31, 2018 | -1,335.99% |
| Sep 30, 2018 | -150.86% |
API Access
Mesoblast Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MESO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "MESO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=MESO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();